Patent: 10,010,556
✉ Email this page to a colleague
Summary for Patent: 10,010,556
| Title: | Bicyclic bromodomain inhibitors |
| Abstract: | The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy. |
| Inventor(s): | Quinn John Frederick, Duffy Bryan Cordell, Liu Shuang, Wang Ruifang, Jiang May Xiaowu, Martin Gregory Scott, Wagner Gregory Steven, Young Peter Ronald |
| Assignee: | Zenith Epigenetics Ltd. |
| Application Number: | US15486256 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,010,556
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Hoffmann-la Roche Inc. | ROFERON-A | interferon alfa-2a | For Injection | 103145 | June 04, 1986 | ⤷ Start Trial | 2037-04-12 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
